KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Molina Healthcare (MOH) Research & Development (2010 - 2018)

Molina Healthcare recorded quarterly Research & Development of $120.0 million in Q1 2018, down 2.44% quarter-over-quarter from $123.0 million in Q4 2017, and down 1.64% year-over-year from $122.0 million in Q1 2017.

Molina Healthcare's Research & Development history runs 9 years deep, the most recent figure standing at $120.0 million for Q1 2018.

  • In Q1 2018, Research & Development fell 1.64% year-over-year to $120.0 million; the TTM figure through Mar 2018 stood at $490.0 million (up 2.08% YoY), while the FY2017 annual figure was $492.0 million, up 1.44% from the prior year.
  • Research & Development came in at $120.0 million for Q1 2018 at Molina Healthcare, down from $123.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $127.0 million in Q1 2016 to a low of $33.0 million in Q2 2015.
  • A 5-year average of $85.1 million and a median of $116.0 million in 2016 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development slipped 15.14% in 2015 and soared 252.78% in 2016, its largest moves.
  • Molina Healthcare's Research & Development stood at $39.2 million in 2014, then soared by 129.77% to $90.0 million in 2015, then surged by 36.67% to $123.0 million in 2016, then changed by 0.0% to $123.0 million in 2017, then slipped by 2.44% to $120.0 million in 2018.
  • According to Business Quant data, Research & Development over the past three periods registered $120.0 million, $123.0 million, and $123.0 million for Q1 2018, Q4 2017, and Q3 2017 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Unitedhealth 345.31 Bn 315.51 Bn 98.90 Bn -
2 Cvs Health 115.41 Bn 103.79 Bn 4.43 Bn -
3 Elevance Health 88.60 Bn 53.18 Bn 13.88 Bn -
4 Cigna 72.05 Bn 64.43 Bn -44.29 Bn -
5 Humana 39.05 Bn 17.15 Bn 4.00 Bn -
6 Centene 30.50 Bn 6.84 Bn 49.24 Bn -
7 Molina Healthcare 9.31 Bn 60.65 Mn 1.53 Bn -
8 Oscar Health 6.86 Bn 63.05 Mn -3.22 Bn -
9 Alignment Healthcare 2.69 Bn 1.96 Bn 135.85 Mn -
10 Progyny 2.12 Bn 1.90 Bn 83.07 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2018 120.00 Mn
Dec 31, 2017 123.00 Mn
Sep 30, 2017 123.00 Mn
Jun 30, 2017 124.00 Mn
Mar 31, 2017 122.00 Mn
Dec 31, 2016 123.00 Mn
Sep 30, 2016 119.00 Mn
Jun 30, 2016 116.00 Mn
Mar 31, 2016 127.00 Mn
Dec 31, 2015 90.00 Mn
Sep 30, 2015 34.00 Mn
Jun 30, 2015 33.00 Mn
Mar 31, 2015 36.00 Mn
Dec 31, 2014 39.17 Mn
Sep 30, 2014 40.07 Mn
Jun 30, 2014 37.11 Mn
Mar 31, 2014 40.66 Mn
Dec 31, 2013 41.81 Mn
Sep 30, 2013 40.11 Mn
Jun 30, 2013 39.31 Mn
Mar 31, 2013 39.77 Mn
Dec 31, 2012 43.10 Mn
Sep 30, 2012 37.00 Mn
Jun 30, 2012 30.61 Mn
Mar 31, 2012 30.49 Mn
Dec 31, 2011 38.97 Mn
Sep 30, 2011 34.58 Mn
Jun 30, 2011 39.22 Mn
Mar 31, 2011 31.22 Mn
Dec 31, 2010 36.79 Mn
Sep 30, 2010 27.61 Mn
Jun 30, 2010 14.25 Mn